Comprehensive Transcriptional Analysis of Early-Stage Urothelial CarcinomaJakob Hedegaard, Lars Dyrskjøt, Philippe Lamy et al.|Cancer Cell|2016Cited by 654
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia V. Lindskrog, Lars Dyrskjøt, Frederik Prip et al.|Nature Communications|2021Cited by 381
Intravascular volume therapy in adultsGernot Marx, Michaela Eikermann, Achim W. Schindler et al.|European Journal of Anaesthesiology|2016Cited by 125
Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancerAnna Katharina Seitz, Lars Dyrskjøt, Lise Lotte Christensen et al.|Scientific Reports|2017Cited by 122
Prognostic Impact of a 12-gene Progression Score in Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Validation StudyLars Dyrskjøt, Torben F. Ørntoft, Thomas Reinert et al.|European Urology|2017Cited by 100